fluorescein-5-isothiocyanate has been researched along with morphine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ayling, P; Colbert, DL; Gallacher, G; Turner, GJ | 1 |
| Chang, WB; Mi, JQ; Zhang, XX | 1 |
| Alnajjar, A; Butcher, JA; McCord, B | 1 |
| Capalash, N; Gandhi, S; Sharma, P; Suri, CR; Verma, RS | 1 |
| Halquist, MS; Hauser, KF; Jones, AM; Kashuba, ADM; Kim, WK; Knapp, PE; Leibrand, CR; Masuda, QN; McRae, M; Paris, JJ | 1 |
5 other study(ies) available for fluorescein-5-isothiocyanate and morphine
| Article | Year |
|---|---|
Development of fluoroimmunoassays for the specific detection of morphine in urine.
Topics: Chromatography, Thin Layer; Codeine; Cross Reactions; Fluorescein-5-isothiocyanate; Fluoresceins; Fluorescence Polarization; Humans; Immunoassay; Morphine; Morphine Derivatives; Papaver; Plants, Medicinal; Thiocyanates | 1988 |
Determination of morphine by capillary zone electrophoresis immunoassay combined with laser-induced fluorescence detection.
Topics: Antibody Specificity; Electrophoresis, Capillary; Fluorescein-5-isothiocyanate; Fluorescence; Humans; Immunoassay; Lasers; Morphine; Sensitivity and Specificity | 2004 |
Determination of multiple drugs of abuse in human urine using capillary electrophoresis with fluorescence detection.
Topics: Codeine; Electrophoresis, Capillary; Fluorescein-5-isothiocyanate; Humans; Morphine; Morphine Derivatives; Spectrometry, Fluorescence | 2004 |
Group-selective antibodies based fluorescence immunoassay for monitoring opiate drugs.
Topics: Animals; Antibodies; Antibody Formation; Antibody Specificity; Codeine; Fluorescein-5-isothiocyanate; Haptens; Hemocyanins; Heroin; Immunoassay; Immunoconjugates; Kinetics; Morphine; Morphine Derivatives; Ovalbumin; Rabbits; Serum Albumin, Bovine; Spectrometry, Fluorescence | 2008 |
HIV-1 Tat and opioids act independently to limit antiretroviral brain concentrations and reduce blood-brain barrier integrity.
Topics: Animals; Anti-HIV Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blood-Brain Barrier; Capillary Permeability; Corpus Striatum; Dextrans; Dideoxynucleosides; Female; Fluorescein-5-isothiocyanate; Heterocyclic Compounds, 3-Ring; Hippocampus; HIV Infections; HIV-1; Lamivudine; Mice; Mice, Transgenic; Models, Biological; Morphine; Neurocognitive Disorders; Oxazines; Piperazines; Pyridones; tat Gene Products, Human Immunodeficiency Virus | 2019 |